NCIC CTG's exemestane clinical trial data on breast cancer presented at ASCO 2011
A large international Canadian-led clinical trial investigating a new way to prevent breast cancer in women at increased risk of developing the disease has found that the drug exemestane reduces this risk by 65 per cent compared with placebo.
Linear Mode
